The event will focus on technologies for integrated, human-based 3D systems – from organoids to organ-on-a-chip. The focus will be on essential building blocks in the areas of the brain, heart, and intestines, disease models, cancer research, and drug screening (screening of active substances). The speakers will set the specific technological priorities and present current methods and developments to the workshop participants. They will provide deep insights into the precision microfabrication of complex tissue and barrier models, the further development of bioinks and biofabricated constructs, and the latest microfluidic platforms – with valves, perfusion, and controlled microenvironments. This is complemented by smart materials for membranes, scaffolds, and soft actuation, highly automated systems for sampling and high-throughput applications, and embedded sensor technology and micro- and nanoelectronics for the precise measurement of electrical, optical, and chemical signals. AI-based imaging pipelines combine data acquisition, analysis, and automated feedback, enabling fully integrated experiments. Together, technological elements form scalable screening platforms that enable a seamless transition from experimental concept to robust, feasible applications.